These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32522012)

  • 1. Analysis of American College of Cardiology/American Heart Association Guideline Author Self-Disclosure Compared With Open Payments Industry Disclosure.
    Dudum R; Sajja A; Amdur RL; Choi BG
    Circ Cardiovasc Qual Outcomes; 2019 Dec; 12(12):e005613. PubMed ID: 32522012
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluating Industry Payments Among Dermatology Clinical Practice Guidelines Authors.
    Checketts JX; Sims MT; Vassar M
    JAMA Dermatol; 2017 Dec; 153(12):1229-1235. PubMed ID: 29049553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Let the Sun Shine In! An Adventure in Open Payments.
    Barry MJ
    Ann Intern Med; 2018 Jan; 168(2):151-152. PubMed ID: 29335735
    [No Abstract]   [Full Text] [Related]  

  • 4. Disclosure UK website gives "illusion of transparency," says Goldacre.
    Kmietowicz Z
    BMJ; 2016 Jul; 354():i3760. PubMed ID: 27384062
    [No Abstract]   [Full Text] [Related]  

  • 5. Author Self-disclosure Compared with Pharmaceutical Company Reporting of Physician Payments.
    Alhamoud HA; Dudum R; Young HA; Choi BG
    Am J Med; 2016 Jan; 129(1):59-63. PubMed ID: 26169886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GMC says it can't force doctors to disclose payments from drug companies.
    Torjesen I
    BMJ; 2016 Jul; 354():i3806. PubMed ID: 27390102
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan.
    Saito H; Ozaki A; Sawano T; Shimada Y; Tanimoto T
    JAMA Netw Open; 2019 Apr; 2(4):e192834. PubMed ID: 31026027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financial Conflicts of Interest Among Authors of Urology Clinical Practice Guidelines.
    Carlisle A; Bowers A; Wayant C; Meyer C; Vassar M
    Eur Urol; 2018 Sep; 74(3):348-354. PubMed ID: 29747945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Industry Relationships Among Authors of Otolaryngology Clinical Practice Guidelines.
    Horn J; Checketts JX; Jawhar O; Vassar M
    JAMA Otolaryngol Head Neck Surg; 2018 Mar; 144(3):194-201. PubMed ID: 29270633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disclosure UK: transparency should no longer be an optional extra.
    Adlington K; Godlee F
    BMJ; 2016 Jul; 354():i3730. PubMed ID: 27383187
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence Underlying Recommendations and Payments from Industry to Authors of the National Comprehensive Cancer Network Guidelines.
    Liu X; Tang LL; Mao YP; Liu Q; Sun Y; Chen L; Lin JC; Ma J
    Oncologist; 2019 Apr; 24(4):498-504. PubMed ID: 30459237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tough-talking journal editor faces accusations of leniency.
    McNeil DG
    N Y Times Web; 2006 Aug; ():F1, F3. PubMed ID: 16906685
    [No Abstract]   [Full Text] [Related]  

  • 13. Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting.
    Williams KM
    Food Drug Law J; 2004; 59(1):45-77. PubMed ID: 15190925
    [No Abstract]   [Full Text] [Related]  

  • 14. "Transparency reports" on industry payments to physicians and teaching hospitals.
    Steinbrook R; Ross JS
    JAMA; 2012 Mar; 307(10):1029-30. PubMed ID: 22336624
    [No Abstract]   [Full Text] [Related]  

  • 15. Financial ties between authors of the clinical practice guidelines and pharmaceutical companies: an example from Japan.
    Saito H; Tani Y; Ozaki A; Sawano T; Shimada Y; Yamamoto K; Tanimoto T
    Clin Microbiol Infect; 2019 Nov; 25(11):1304-1306. PubMed ID: 31401175
    [No Abstract]   [Full Text] [Related]  

  • 16. Already feeling the heat: Docs rethinking payments as Sunshine Act looms.
    Lee J
    Mod Healthc; 2013 Jul; 43(26):12-3. PubMed ID: 23878901
    [No Abstract]   [Full Text] [Related]  

  • 17. Ethics and Disclosure.
    Pinzur MS
    Foot Ankle Int; 2019 Mar; 40(3):364. PubMed ID: 30700164
    [No Abstract]   [Full Text] [Related]  

  • 18. Transparency urged over research payments.
    Check E
    Nature; 2007 Aug; 448(7155):738. PubMed ID: 17700667
    [No Abstract]   [Full Text] [Related]  

  • 19. Discrepancies in Conflict-of-Interest Disclosures Among Physicians Receiving Compensation for Monoclonal Antibody Drugs.
    Mesiti A; Herre M; Jafari MD; Pigazzi A
    J Gen Intern Med; 2024 May; 39(7):1135-1141. PubMed ID: 37962731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New rules on conflict of interest: what has to be done in Europe?
    Jirillo A; Vascon F
    Tumori; 2010; 96(1):180-1. PubMed ID: 20437882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.